Snowdome is inviting applications in multiple myeloma that focuses on CAR T-cell therapy. The purpose of this Grant is to accelerate the clinical implementation of CAR T-cell treatments for patients with myeloma and related diseases through the support of cutting-edge, high-quality translational existing or planned clinical trials and studies. The research must provide a step towards impact for patients.

The successful applicant will receive a maximum funding of $150,000 per year for up to three (3) years. Total funding available is $450,000.

For more information and to apply, click here.